Xeomin Approved as First-Line Treatment for Blepharospasm
The FDA has approved Xeomin (incobotulinumtoxinA; Merz) as a first-line treatment for blepharospasm in adults.
Dystonia
Ventro-Oral Thalamotomy Improves Refractory Focal Hand Dystonia
Of the 18 patients with recurrent dystonic symptoms, 7 of the 9 who underwent repeat ventro-oral thalamotomy achieved improvement.Of the 18 patients with recurrent dystonic symptoms, 7 of the 9 who underwent repeat ventro-oral thalamotomy achieved improvement.
Movement Execution Induces STDT Changes With Focal Dystonias
The use of somatosensory temporal discrimination testing did not incite any changes in the mean velocity of index finger movements in either patients with dystonia or healthy controls.
Medical Cannabis Promising for Dystonia Improvement in Pediatric Motor Disorders
Children with a complex motor disorder, characterized by a combination of movement and posture abnormalities (eg, spasticity and dystonia), were enrolled.
Researchers Identify Demographic, Clinical Variables of Oromandibular Dystonia
Researchers collected and analyzed data on age at onset, sex, family history of dystonia, and the presence of associated anatomic sites with dystonia.
Effect of Escitalopram on Motor, Psychiatric Symptoms in Cervical Dystonia
Although treatment with botulinum toxin is effective for pain and posturing associated with cervical dystonia, myoclonus and tremor remain difficult to treat and contribute to compromised quality of life for patients with this movement disorder.
Managing Dystonia With Noninvasive Brain Stimulation: Therapy Update
There is speculation that dystonia is the result of dysfunction occurring in either the cerebellum or basal ganglia or as a result of an abnormal interaction between the two.
Cerebellar Deficit in Dystonia Improved With Alcohol
Alcohol improves cerebellar-learning deficit in patients with myoclonus-dystonia.
Updated Treatment Guidelines for the Use of Botulinum Toxin in Spasticity, Headache
Treatment of chronic, but not episodic migraine with botulinum toxin has been added to the treatment guidelines.
Dystonia, Parkinson’s Disease Share Motor Cortex Synchronization
The disorders react similarly to basal ganglia deep brain stimulation.
